Antibody Analytics

We apply immunology and cell-based assays and couple this with cell and tissue-based expression analysis for hypothesis testing and target validation. We are differentiated by the time and effort we invest in understanding your key questions, and contexualising this with the underlying biology. This enables us to apply the most appropriate complex model systems relevant to your target and the disease biology. Our cell biology experts will assemble and evaluate the published information on your novel target and collaborate with you to select the best in vitro models to achieve your objectives. Learn more chevron_right 02 Lead Selection Starting from a position of deep understanding of the biology of your therapeutic target, we apply a multi-step screening process that links binding characterisation with functional assays of increasing physiological relevance, allowing triaging of drug candidates based on desired characteristics. The two key attributes for selection are the interaction with the target of interest and the ability to modify target biology. We can design and conduct a range of binding and functional assessments, starting with antigen binding analysis by SPR, ELISA or flow cytometry to cell-based reporter systems, ultimately leveraging complex primary cell assays for the most promising candidates. We work in collaboration with our partners, enriching discovery campaigns with reliable data, driving decision making with confidence.

We apply immunology and cell-based assays and couple this with cell and tissue-based expression analysis for hypothesis testing and target validation. We are differentiated by the time and effort we invest in understanding your key questions, and contexualising this with the underlying biology. This enables us to apply the most appropriate complex model systems relevant to your target and the disease biology. Our cell biology experts will assemble and evaluate the published information on your novel target and collaborate with you to select the best in vitro models to achieve your objectives. Learn more chevron_right 02 Lead Selection Starting from a position of deep understanding of the biology of your therapeutic target, we apply a multi-step screening process that links binding characterisation with functional assays of increasing physiological relevance, allowing triaging of drug candidates based on desired characteristics. The two key attributes for selection are the interaction with the target of interest and the ability to modify target biology. We can design and conduct a range of binding and functional assessments, starting with antigen binding analysis by SPR, ELISA or flow cytometry to cell-based reporter systems, ultimately leveraging complex primary cell assays for the most promising candidates. We work in collaboration with our partners, enriching discovery campaigns with reliable data, driving decision making with confidence.

Contact Antibody Analytics

Antibody Analytics Discovery Centre, Braidhurst Industrial Estate, Motherwell ML1 3ST